Passive Antibody Administration (Immediate Immunity) as a Specific Defense Against Biological Weapons

Casadevall, Arturo

Back to Previous Page

- Add this to...
- Twitter
- Facebook
- Google Bookmarks
- LinkedIn

Passive Antibody Administration (Immediate Immunity) as a Specific Defense Against Biological Weapons

Published Date:

Aug 2002

Source:

Emerg Infect Dis. 8(8):833-841.

[PDF-288.17 KB]

Details:

Personal Authors:

Casadevall, Arturo

Keywords:

[+]

Description:

The potential threat of biological warfare with a specific agent is proportional to the susceptibility of the population to that agent. Preventing disease after exposure to a biological agent is partially a function of the immunity of the exposed individual. The only available countermeasure that can provide immediate immunity against a biological agent is passive antibody. Unlike vaccines, which require time to induce protective immunity and depend on the host's ability to mount an immune response, passive antibody can theoretically confer protection regardless of the immune status of the host. Passive antibody therapy has substantial advantages over antimicrobial agents and other measures for postexposure prophylaxis, including low toxicity and high specific activity. Specific antibodies are active against the major agents of bioterrorism, including anthrax, smallpox, botulinum toxin, tularemia, and plague. This article proposes a biological defense initiative based on developing, producing, and stockpiling specific antibody reagents that can be used to protect the population against biological warfare threats.

Document Type:

Journal Article

Collection(s):

Emerging Infectious Diseases

Supporting Files:

01-0516_FinalP.nxml	text/plain
license.txt	text/plain

No Related Documents.

You May Also Like:

Tametomo no bui toukigami wo shirizoku zu

Personal Author:

Potter, Polyxeni

Published:

Jul 2002

Source:

Emerg Infect Dis. 8(7):752.

File Type:

[PDF - 147.22 KB]
First National Symposium on Medical and Public Health Response to Bioterrorism

Personal Author:

Henderson, Donald A. (Donald Ainslie), 1928-2016.; Shalala, Donna E.; Hughes, James M.; McCann, S. Anthony; Clarke, Richard A.; Tucker, Jonathan B.; Siegrist, David W.; Davis, Christopher J.; Olson, Kyle B.; Stern, Jessica; Kortepeter , Mark G.; Parker, Gerald W.; Pavlin, Julie A.; Russell, Philip K.; Zoon, Kathryn C.; O’Toole, Tara; Jason Bardi; Cieslak, Theodore J.; Eitzen, Edward M.; Inglesby, Thomas V.; Bartlett, John G.; Hamburg, Margaret A.;

Corporate Author:

National Center for Infectious Diseases (U.S.)

Conference Author:

National Symposium on Medical and Public Health Response to Bioterrorism (1999 : Baltimore, MD)

Published:

July–August 1999

Series:

Emerginc infectious diseases ; v. 5, no. 4, p. 491-565

Description:

On February 16-17, 1999, in Arlington, Virginia, 950 public health officials, physicians, and other medical personnel, along with government, military, and intelligence experts gathered for the first National Symposium on Medical and Public Health Re...

File Type:

[PDF - 3.78 MB]
CDC bulletin, vol. X, no. 7, July 1951.

Personal Author:

Culler, J. W.; Dwiggins, John F.; Flinn, Robert H.; Habel, Karl; Kiefer, Norvin C.; Knight, Vernon; Wegman, Myron E., 1908-;

Corporate Author:

Communicable Disease Center (U.S.); Conference of State Epidemiologists on National Morbidity Reporting (1951 : Atlanta, GA); United States. National Office of Vital Statistics.;

Published:

July 1951

Description:

On cover: National Morbidity Reporting. : The first four articles were presented at the Conference of State Epidemiologists on National Morbidity Reporting held April 18-20, 1951 at the Fulton County Academy of Medicine, Atlanta, Ga., under the spons...

File Type:

[PDF - 17.10 MB]
Vaccines, pharmaceutical products, and bioterrorism: challenges for the U.S. Food and Drug Administration.

Personal Author:

Zoon, K. C.

Published:

1999 Jul-Aug

Source:

Emerg Infect Dis. 5(4):534-536.

File Type:

[PDF - 66.12 KB]
Anthrax as a Biological Weapon, 2002 - Updated Recommendations for Management

Corporate Author:

Johns Hopkins Center for Civilian Biodefense Strategies

Source:

JAMA : the journal of the American Medical Association. 2002; 287(17):2236-52.

Status:

current

File Type:

[PDF - 369.19 KB]